Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad RH, Berlin M, Hazan A, Richardson JL, Eleftheriou G, Rousson V, Diezi L, Haefliger D, Simões-Wüst AP, Addor MC, Baud D, Lamine F, Panchaud A, Buclin T, Girardin FR, Winterfeld U. Dao K, et al. Among authors: weber schoendorfer c. BMJ Open. 2024 Apr 24;14(4):e083550. doi: 10.1136/bmjopen-2023-083550. BMJ Open. 2024. PMID: 38663923 Free PMC article.
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E, Onken M, Weber-Schoendorfer C, Rousson V, Addor MC, Baud D, Théaudin M, Diav-Citrin O, Cottin J, Agusti A, Rollason V, Kaplan YC, Kennedy D, Kadioglu M, Rothuizen LE, Livio F, Buclin T, Panchaud A, Winterfeld U. Pauliat E, et al. Among authors: weber schoendorfer c. Mult Scler. 2021 Mar;27(3):475-478. doi: 10.1177/1352458520929628. Epub 2020 Jun 15. Mult Scler. 2021. PMID: 32538681
Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N; Network of French Pharmacovigilance Centers; Shechtman S, Johnson D, Cuppers-Maarschalkerweerd B, Pistelli A, Clementi M, Winterfeld U, Eleftheriou G, Pupco A, Kao K, Malm H, Elefant E, Koren G, Vial T, Ornoy A, Meister R, Schaefer C. Weber-Schoendorfer C, et al. Arthritis Rheumatol. 2014 May;66(5):1101-10. doi: 10.1002/art.38368. Arthritis Rheumatol. 2014. PMID: 24470106
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N; network of French pharmacovigilance centres; Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadioglu Duman M, Meister R, Schaefer C. Weber-Schoendorfer C, et al. Br J Clin Pharmacol. 2015 Oct;80(4):727-39. doi: 10.1111/bcp.12642. Epub 2015 May 28. Br J Clin Pharmacol. 2015. PMID: 25808588 Free PMC article.
Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
Damkier P, Kaplan YC, Shechtman S, Diav-Citrin O, Cassina M, Weber-Schoendorfer C. Damkier P, et al. Among authors: weber schoendorfer c. Basic Clin Pharmacol Toxicol. 2021 Apr;128(4):579-582. doi: 10.1111/bcpt.13541. Epub 2020 Dec 16. Basic Clin Pharmacol Toxicol. 2021. PMID: 33275828 Free article.
Methotrexate in pregnancy: still many unanswered questions.
Weber-Schoendorfer C, Diav-Citrin O. Weber-Schoendorfer C, et al. RMD Open. 2023 Mar;9(1):e002899. doi: 10.1136/rmdopen-2022-002899. RMD Open. 2023. PMID: 36921981 Free PMC article. No abstract available.
The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.
Bar-Oz B, Weber-Schoendorfer C, Berlin M, Clementi M, Di Gianantonio E, de Vries L, De Santis M, Merlob P, Stahl B, Eleftheriou G, Maňáková E, Hubičková-Heringová L, Youngster I, Berkovitch M. Bar-Oz B, et al. Drug Saf. 2012 Jul 1;35(7):589-98. doi: 10.2165/11630920-000000000-00000. Drug Saf. 2012. PMID: 22702640
40 results